about
sameAs
Vitamin C and superoxide dismutase (SOD) for diabetic retinopathyErytrocyte membrane anionic charge in type 2 diabetic patients with retinopathyThe Adenosinergic System in Diabetic RetinopathyContribution of microglia-mediated neuroinflammation to retinal degenerative diseasesTreatment of diabetic retinopathy: Recent advances and unresolved challengesDiabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies.Mesenchymal stem cell-based treatment for microvascular and secondary complications of diabetes mellitus.Evolving strategies in the management of diabetic retinopathyThe cost-effectiveness of three screening alternatives for people with diabetes with no or early diabetic retinopathy.Increased serum levels of uric acid are associated with sudomotor dysfunction in subjects with type 2 diabetes mellitusNanoengineering of therapeutics for retinal vascular disease.High Mannose-Binding Lectin Serum Levels Are Associated with Diabetic Retinopathy in Chinese Patients with Type 2 Diabetes.Progression of diabetic retinopathy correlated with muscle perfusion disturbances of the lower limbs, with clinically important diagnostic recommendationsTransgenic Mice Overexpressing Serum Retinol-Binding Protein Develop Progressive Retinal Degeneration through a Retinoid-Independent Mechanism.Sulfonylurea use and the risk of hospital readmission in patients with type 2 diabetes.Association of Complement C5 Gene Polymorphisms with Proliferative Diabetic Retinopathy of Type 2 Diabetes in a Chinese Han Population.Per2-Mediated Vascular Dysfunction Is Caused by the Upregulation of the Connective Tissue Growth Factor (CTGF).Effect of focal laser photocoagulation in eyes with mild to moderate non-proliferative diabetic retinopathy.Linkage Analysis of Genomic Regions Contributing to the Expression of Type 1 Diabetes Microvascular Complications and Interaction with HLADiabetic retinopathy in a multi-ethnic cohort in the United States.Evaluating digital diabetic retinopathy screening in people aged 90 years and over.Diabetes Education, Specialty Care, and Self-Care Advice among Obese African American Women with Type 2 Diabetes.HLA class I and II alleles are associated with microvascular complications of type 1 diabetes.Role of TGF-beta in proliferative vitreoretinal diseases and ROCK as a therapeutic target.Botanical compounds: effects on major eye diseasesTCF7L2 variation and proliferative diabetic retinopathyA Multi-Center Diabetes Eye Screening Study in Community Settings: Study Design and Methodology.Extravascular modified lipoproteins: a role in the propagation of diabetic retinopathy in a mouse model of type 1 diabetes.The relationship between diabetic retinopathy and cognitive impairmentEvaluating Adherence to Dilated Eye Examination Recommendations Among Patients with Diabetes, Combined with Patient and Provider PerspectivesFactors contributing to diabetes patients not receiving annual dilated eye examinations.Incidence of diabetes-related complications in Chinese patients with type 1 diabetes: a population-based longitudinal cohort study in Taiwan.Diabetic retinopathy: reversibility of epigenetic modifications and new therapeutic targets.ROCK as a Therapeutic Target of Diabetic RetinopathyAldose reductase C-106T gene polymorphism in type 2 diabetics with microangiopathy in Iranian individuals.Haptoglobin polymorphism in individuals with type 2 diabetic microangiopathy.Haptoglobin2-2 phenotype is an additional risk factor of retinopathy in type 2 diabetes mellitus.CX3CR1 deficiency accelerates the development of retinopathy in a rodent model of type 1 diabetes.Diabetic retinopathy screening using tele-ophthalmology in a primary care setting.The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic P
P2860
Q24242326-609BFA1A-0CDA-413A-8F5D-59BFDE7C86F0Q24792124-1538C2B2-9F13-4DEE-B920-6CA3CD34D752Q26748944-4E3188E2-0159-44F4-A340-946467C09B8AQ27007111-19B1DE8A-3163-49BA-8607-6873323DAAFEQ28067491-789F1884-AD15-4E16-9430-522781A57873Q33649275-4D554E53-C65A-4BA9-B877-BD52745D3E0DQ33719419-AA661106-3DA2-4F86-A29A-8F94B1E56940Q35067102-B5E6A055-5AF5-46AF-A76A-72C2B183FC98Q35194580-8C205EDC-F43F-4722-8252-FA771304B1BAQ35219367-DB3A5648-2A1E-448F-82B9-EF4235597BE9Q35645705-D00912FE-EB41-42D6-B950-F1F48EA616BAQ35681309-CFC34A46-BB9B-4DFF-938D-3BACCCFA98C2Q35827389-AFE2C4E4-B8B4-4A8F-83CA-DA50D31F643FQ35868411-F76A6AA6-8559-419A-9116-FAC1AC059162Q35898272-7F00885A-F3B2-4EE4-8EF2-7CC5E443F6FCQ35943170-A165D9F4-2747-4FBF-8BA8-ACD0A1324F08Q36143132-2E95336A-D919-4E07-BA4E-356086A025C7Q36179824-B773AB18-54BD-4CD7-9A2C-98DD210D392BQ36204486-DFD4EEF5-63E8-44FB-BBD8-33D03FCCBC64Q36464921-382B5121-21D4-49E4-A257-58C5BA363934Q36750312-E7D866BB-ECE9-48E6-92BD-1B758BA3BC92Q36813331-42413580-FAF2-4AE7-9258-FAD80D616539Q36940316-80FEA546-9268-4CA8-9DC8-6857C736EFDFQ36970828-CFE8F389-F40C-49E8-A4A1-B934DBA282FAQ36988482-1BAA3990-1357-4102-9D6D-776CFC2E9521Q37015022-30476A21-E87B-4356-AA01-872D3E4D4440Q37024278-408C2AE1-919C-4B51-BD32-F99FB6AEFB76Q37143813-113C5572-845F-4758-B4B1-71CDAA3B6269Q37193439-2C4D64F7-409F-4CB1-A5BB-3F8DDBE89EB9Q37441401-FDB5D589-FC53-4F54-9BBC-E5538B078E3AQ39421223-602A40AD-6244-4988-8B88-03A4440203A7Q40150694-6063CB6D-63C1-40A6-9F6D-11904A9EF970Q41413793-0D210E4F-478D-4BCF-A659-47C2C9B1C086Q41873958-382AAEED-F1B5-4BCA-BF93-8487EE8CB945Q41965143-718D2B80-F1A4-4143-A196-511660A62DF7Q42001856-61668B6B-69DF-4568-855A-3E79A3A1F913Q42578954-80FA0672-061F-4E1A-B14D-3A4A8C2DE4B6Q42709409-8965ADB2-CEAC-4D91-9AAE-4DDBEBCCE10AQ42919041-76862D7C-A95E-49E5-B7F3-2EA57B73890BQ44648415-6C935925-18DA-4E8E-B8DC-684810E07B5D
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Diabetic retinopathy
@ast
Diabetic retinopathy
@en
Diabetic retinopathy
@nl
type
label
Diabetic retinopathy
@ast
Diabetic retinopathy
@en
Diabetic retinopathy
@nl
prefLabel
Diabetic retinopathy
@ast
Diabetic retinopathy
@en
Diabetic retinopathy
@nl
P2093
P3181
P1433
P1476
Diabetic retinopathy
@en
P2093
American Diabetes Association
Donald S Fong
Fredrick L Ferris
George Blankenship
George L King
Jerry D Cavallerano
Lloyd Aiello
Thomas W Gardner
P304
P3181
P356
10.2337/DIACARE.26.2007.S99
P407
P478
26 Suppl 1
P50
P577
2003-01-01T00:00:00Z